These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10843658)

  • 41. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
    Telford WG; Nam SY; Podack ER; Miller RA
    Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immune tolerance inducing effects of soluble human leucocyte antigen G1 on natural killer cells and T cells].
    Fang CY; Wu XW; Liang ZH; Chen H; Han JY; Huang YF; Gong FL
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):584-7. PubMed ID: 12887750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules.
    Fournel S; Huc X; Aguerre-Girr M; Solier C; Legros M; Praud-Brethenou C; Moussa M; Chaouat G; Berrebi A; Bensussan A; Lenfant F; Le Bouteiller P
    Tissue Antigens; 2000 Jun; 55(6):510-8. PubMed ID: 10902607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity.
    Jodo S; Hohlbaum AM; Xiao S; Chan D; Strehlow D; Sherr DH; Marshak-Rothstein A; Ju ST
    J Immunol; 2000 Nov; 165(10):5487-94. PubMed ID: 11067901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes.
    Zavazava N; Krönke M
    Nat Med; 1996 Sep; 2(9):1005-10. PubMed ID: 8782458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand.
    Contini P; Zocchi MR; Pierri I; Albarello A; Poggi A
    Leukemia; 2007 Feb; 21(2):253-60. PubMed ID: 17170722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF; Green WR
    J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.
    Hackmon R; Hallak M; Krup M; Weitzman D; Sheiner E; Kaplan B; Weinstein Y
    Fetal Diagn Ther; 2004; 19(5):404-9. PubMed ID: 15305096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes.
    Bahri R; Hirsch F; Josse A; Rouas-Freiss N; Bidere N; Vasquez A; Carosella ED; Charpentier B; Durrbach A
    J Immunol; 2006 Feb; 176(3):1331-9. PubMed ID: 16424159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
    Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
    J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD95 ligand expression as a mechanism of immune escape in breast cancer.
    Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
    Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulation of T cell responses by a subpopulation of CD8+DEC205+ murine dendritic cells.
    Kronin V; Süss G; Winkel K; Shortman K
    Adv Exp Med Biol; 1997; 417():239-48. PubMed ID: 9286368
    [No Abstract]   [Full Text] [Related]  

  • 57. HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.
    Lee JW; Gersuk GM; Kiener PA; Beckham C; Ledbetter JA; Deeg HJ
    J Immunol; 1997 Oct; 159(7):3211-9. PubMed ID: 9317119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells.
    Petrovas C; Mueller YM; Yang G; Altork SR; Jacobson JM; Pitsakis PG; Mounzer KC; Altman JD; Katsikis PD
    Apoptosis; 2007 Dec; 12(12):2175-86. PubMed ID: 17891455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness.
    Ferguson TA; Herndon J; Elzey B; Griffith TS; Schoenberger S; Green DR
    J Immunol; 2002 Jun; 168(11):5589-95. PubMed ID: 12023355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.